Breaking News from Peru, Show

from Bing and Google News
Peru , Wednesday 15 April 2026

miRagen Announces New Clinical Data for Cobomarsen in ATLL Patients at the 19th Annual HTLV Congress in Lima, Peru

Published on: Thursday 25 April 2019

biomarkers that have been associated with poor prognosis were reduced following cobomarsen treatment Cobomarsen continues to show good tolerability with no serious adverse events deemed related to ...



Share this news on:  

RELATED NEWS